901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster II

Impact of an Individualized Pain Plan (IPP) for Adults with Sickle Cell Disease Experiencing a Vaso-Occlusive Episode (VOE) on Patient Satisfaction an

Outpatient Management of Sickle Cell Vaso-Occlusive Crisis As a Strategy of Decreasing Emergency Department Visits

Use of an Advance Chart Preparation Process Improves Overall Care in Pediatric Patients with Sickle Cell Disease

VOC-Free Status Among Patients with Sickle Cell Disease Following Allogeneic Hematopoietic Stem Cell Transplant: A Cohort Study of Medicaid Enrollees

Distinguishing the Variances in Patient Care between Hematologists and Hospitalists for Individuals with Sickle Cell Disease Hospitalized Due to Vaso-

Utilization of Pharmacologic and Non-Pharmacologic Therapies for Pain in Sickle Cell Disease: A Cross-Sectional Study

Current Practice in Counseling about Sickle Cell Disease-Modifying Therapy and Sexual and Reproductive Health

Patients, Parents and Providers Perspectives Toward Treatment Options for Sickle Cell Disease

Addressing Chronic Anemia in Sickle Cell Disease: Characterizing Erythropoiesis-Stimulating Agent (ESA) Utilization and Practice Patterns Among Provid

The Quest for Improving Sickle Cell Care: Creating High-Level Quality Improvement Goals with a Care Process Team

Inaccuracy of Initial Clinical Mobility Assessment in Venous Thromboembolism Risk Stratification

Attitudes of Hematologists in the Midwestern United States Toward Evaluating and Managing Thrombosis Risk in Transgender Youth Starting Gender Affirmi

Evaluation of Venous Thromboembolism Prevention Practices in US Hospitals

Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis

Factor First: An Assessment of Emergency Department Care of Patients with Hemophilia

E-Iron: An Asynchronous Telemedicine Referral Platform for Management of Anemic Pregnant Patients and the Expediting of Treatment with Intravenous Iro

Cross-Community Collaboration and Data Collection to Optimize Patient Care in Hemolytic Anemias

Therapeutic Apheresis in Rural and Regional Settings: A Single-Centre 5-Year Experience

Racial Disparity in Hematopoietic Stem Cell Transplant Clinical Trial Recruitment

Design Characteristics and Risk of Bias of Pivotal Trials Supporting Approval of Hematological Drugs By FDA, 2008-2022: Cross Sectional Analysis

Comparison of Projected Hemophilia a Populations Residing in Hospital Referral Regions with and without Hemophilia Treatment Centers in the US

Iron Deficiency Anemia: The Impact of Intravenous Iron Replacement Treatment on Health Care Costs

Unlocking Global Potential: Education and Funding Opportunities for International Trainees in Hematology